Trial intelligence / Profile preview

Efficacy and Safety of Inactivated EV71 Vaccine in Chinese Children

NCT01508247Phase 3Completed

Sponsor
Jiangsu Provincial Center for Disease Control and Prevention
Start
Jan 2012
Primary completion
Mar 2013
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 3 trial of enterovirus 71 vaccine (vero cell), inactivated in HIV-associated central nervous system involvement (HAND), herpangina, enterovirus 71 infection, sponsored by Jiangsu Provincial Center for Disease Control and Prevention. Started Jan 2012; status: completed.

02

Drugs

enterovirus 71 vaccine (vero cell), inactivated
03

Conditions

HIV-associated central nervous system involvement (HAND)herpanginaenterovirus 71 infection

Beyond the preview

Go deeper on NCT01508247.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01508247.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call